T
Thomas Kerr
Researcher at University of British Columbia
Publications - 747
Citations - 32536
Thomas Kerr is an academic researcher from University of British Columbia. The author has contributed to research in topics: Population & Poison control. The author has an hindex of 84, co-authored 722 publications receiving 28727 citations. Previous affiliations of Thomas Kerr include Providence Health Care & Center for Excellence in Education.
Papers
More filters
Journal ArticleDOI
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
Julio S. G. Montaner,Julio S. G. Montaner,Julio S. G. Montaner,Viviane D. Lima,Viviane D. Lima,Rolando Barrios,Benita Yip,Evan Wood,Evan Wood,Thomas Kerr,Thomas Kerr,Kate Shannon,Kate Shannon,P. Richard Harrigan,P. Richard Harrigan,Robert S. Hogg,Robert S. Hogg,Patricia Daly,Perry Kendall +18 more
TL;DR: A population-level association between increasing HAART coverage, decreased viral load, and decreased number of new HIV diagnoses per year is shown, which supports the proposed secondary benefit of HAART used within existing medical guidelines to reduce HIV transmission.
Journal ArticleDOI
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
Julio S. G. Montaner,Robert S. Hogg,Evan Wood,Thomas Kerr,Mark W. Tyndall,Adrian R. Levy,P. Richard Harrigan +6 more
TL;DR: The potential role of HAART in HIV prevention and the resulting impact this would have on the cost-eff ectiveness of the treatment are examined.
Journal ArticleDOI
Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work
TL;DR: Analysis of the narratives and daily lived experiences of women sex workers highlight the urgent need for a renewed HIV prevention strategy that moves beyond a solely individual-level focus to structural and environmental interventions that facilitate 'enabling environments' for HIV prevention.
Journal ArticleDOI
Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
TL;DR: Whether the opening of an SIF in Vancouver, BC, Canada, was associated with a reduction in overdose mortality is sought and supervised injecting facilities should be considered where injection drug use is prevalent, particularly in areas with high densities of overdose.
Journal ArticleDOI
Public health and international drug policy
Joanne Csete,Adeeba Kamarulzaman,Michel D. Kazatchkine,Frederick L. Altice,Marek Balicki,Julia Buxton,Javier A. Cepeda,Megan Comfort,Eric Goosby,João Goulão,Carl L. Hart,Thomas Kerr,Alejandro Madrazo Lajous,Stephen R. Lewis,Natasha K. Martin,Daniel Mejía,Adriana Camacho,David Scott Mathieson,Isidore Obot,Adeolu Ogunrombi,Susan G. Sherman,Jack Stone,Nandini Vallath,Peter Vickerman,Tomáš Zábranský,Chris Beyrer +25 more
TL;DR: The Johns Hopkins-Lancet Commission on Drug Policy and Health as mentioned in this paper examined the emerging scientific evidence on public health issues arising from drug control policy and to inform and encourage a central focus on health evidence and outcomes in drug-policy debates, such as the important deliberations of the 2016 UNGASS on drugs.